Sectors & IndustriesConsumer DefensivePharmaceutical Retailers

Best Pharmaceutical Retailer Stocks to Buy Now (2024)

Top pharmaceutical retailer stocks in 2024 ranked by overall Due Diligence Score. See the best pharmaceutical retailer stocks to buy now, according to analyst forecasts for the pharmaceutical retailers industry.

According to Due Diligence Score, the 3 best drug store stocks to buy right now are:

Scienture Holdings (NASDAQ:SCNX) is the top pharmaceutical retailer stock with a Due Diligence Score of 35, which is 11 points higher than the pharmaceutical retailer industry average of 24. It passed 12 out of 38 due diligence checks and has average fundamentals. Scienture Holdings has seen its stock return 31.01% over the past year, overperforming other pharmaceutical retailer stocks by 68 percentage points.

Sunlink Health Systems (NYSEMKT:SSY) is the second best pharmaceutical retailer stock with a Due Diligence Score of 31, which is 7 points higher than the pharmaceutical retailer industry average of 24. It passed 9 out of 33 due diligence checks and has average fundamentals. Sunlink Health Systems has seen its stock lose -13.79% over the past year, overperforming other pharmaceutical retailer stocks by 23 percentage points.

High Tide (NASDAQ:HITI) is the third best pharmaceutical retailer stock with a Due Diligence Score of 27, which is 3 points higher than the pharmaceutical retailer industry average of 24. It passed 9 out of 33 due diligence checks and has average fundamentals. High Tide has seen its stock return 98.75% over the past year, overperforming other pharmaceutical retailer stocks by 136 percentage points.

High Tide has an average 1 year price target of $4.50, an upside of 41.51% from High Tide's current stock price of $3.18.

High Tide stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering High Tide, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

Out of 2 pharmaceutical retailer stocks that have issued dividends in the past year, the 2 pharmaceutical retailer stocks with the highest dividend yields are:

Scienture Holdings (NASDAQ:SCNX) has an annual dividend yield of 18.59%, which is 4 percentage points higher than the pharmaceutical retailer industry average of 14.37%.

Scienture Holdings's dividend payout ratio of 302.5% indicates that its high dividend yield might not be sustainable for the long-term.

Walgreens Boots Alliance (NASDAQ:WBA) has an annual dividend yield of 10.16%, which is -4 percentage points lower than the pharmaceutical retailer industry average of 14.37%. Walgreens Boots Alliance's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Walgreens Boots Alliance's dividend has not shown consistent growth over the last 10 years.

Walgreens Boots Alliance's dividend payout ratio of -12.3% indicates that its high dividend yield might not be sustainable for the long-term.

Pharmaceutical retailer stocks were down -3.75% in the last day, and up 5.89% over the last week.

We couldn't find a catalyst for why pharmaceutical retailer stocks are down.

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical retailer stocks right now are:

Scienture Holdings (NASDAQ:SCNX) is the most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Scienture Holdings has a valuation score of 43, which is 32 points higher than the pharmaceutical retailer industry average of 11. It passed 3 out of 7 valuation due diligence checks.

Scienture Holdings's stock has gained 31.01% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 68 percentage points.

Sunlink Health Systems (NYSEMKT:SSY) is the second most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. Sunlink Health Systems has a valuation score of 14, which is 3 points higher than the pharmaceutical retailer industry average of 11. It passed 1 out of 7 valuation due diligence checks.

Sunlink Health Systems's stock has dropped -13.79% in the past year. It has overperformed other stocks in the pharmaceutical retailer industry by 23 percentage points.

China Jo Jo Drugstores (NASDAQ:CJJD) is the third most undervalued pharmaceutical retailer stock based on WallStreetZen's Valuation Score. China Jo Jo Drugstores has a valuation score of 14, which is 3 points higher than the pharmaceutical retailer industry average of 11. It passed 1 out of 7 valuation due diligence checks.

China Jo Jo Drugstores's stock has dropped -57.51% in the past year. It has underperformed other stocks in the pharmaceutical retailer industry by -20 percentage points.